|
|
|
Volumn 60, Issue SUPPL. 1, 1999, Pages 23-25
|
|
New vs. old antipsychotics: The Texas experience
a,b
b
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
PHENOTHIAZINE DERIVATIVE;
AGRANULOCYTOSIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DISEASE ASSOCIATION;
DRUG COST;
HEALTH CARE COST;
HOSPITALIZATION;
HUMAN;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
QUALITY OF LIFE;
SCHIZOPHRENIA;
SEIZURE;
SUICIDE;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
FOLLOW-UP STUDIES;
HEALTH CARE COSTS;
HOSPITAL COSTS;
HOSPITALIZATION;
HUMANS;
LENGTH OF STAY;
RETROSPECTIVE STUDIES;
SCHIZOPHRENIA;
SUICIDE;
TEXAS;
TREATMENT OUTCOME;
|
|
EID: 0032966566
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (10)
|
|
References (8)
|
